Floatz logo

Therapeutic Asset Ratings

462 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Catch T Cells
Neoplasm
Baylor College of MedicineP1C (36)
Cbp-1018
Neoplasm
Coherent Biopharma (Suzhou) Co., Ltd.P1C (36)
Cbp-1019
Neoplasm
M.D. Anderson Cancer CenterP1C (36)
cct303-406
Neoplasm
Shanghai PerHum Therapeutics Co., Ltd.P1C (36)
Cedazuridine
Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1C (36)
cf33-hnis
Neoplasm
Imugene LimitedP1C (36)
Cldn6 Car-T
Neoplasm
BioNTech Cell & Gene Therapies GmbHP1C (36)
Cldn6 Urna-Lpx/Cldn6 Modrna-Lpx
Neoplasm
BioNTech Cell & Gene Therapies GmbHP1C (36)
Cpg-Odn
Neoplasm
Second Affiliated Hospital of Guangzhou Medical UniversityP1C (36)
Cusp06
Neoplasm
OnCusp Therapeutics, Inc.P1C (36)
Dfp-14927
Neoplasm
Delta-Fly Pharma, Inc.P1C (36)
dk210
Neoplasm
DEKA BiosciencesP1C (36)
dr30206
Neoplasm
Zhejiang Doer Biologics Co., Ltd.P1C (36)
Drug: Ibi3028
Neoplasm
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.P1C (36)
ds-1055a
Neoplasm
Daiichi SankyoP1C (36)
Dxp-106
Neoplasm
Singlomics Biopharmaceuticals Zhuhai Co., Ltd.P1C (36)
Ecp-1014
Neoplasm
Euclises Pharmaceuticals, Inc.P1C (36)
Enoblituzumab
Neoplasm
Masonic Cancer Center, University of MinnesotaP1C (36)
es014
Neoplasm
Elpiscience (Suzhou) Biopharma, Ltd.P1C (36)
Etakafusp Alfa
Neoplasm
Asher Biotherapeutics, Inc.P1C (36)
eu103
Neoplasm
EutilexP1C (36)
exs74539
Neoplasm
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1C (36)
Fcn-098
Neoplasm
Fochon Pharmaceuticals, Ltd.P1C (36)
ftl001
Neoplasm
Sound Biopharmaceuticals Ltd.P1C (36)
gc203 til
Solid Tumor
Shanghai Juncell TherapeuticsP1C (36)
Showing 301 to 325 of 462 assets
PreviousPage 13 of 19Next